Continue to Limit Celecoxib and Other NSAIDs in High-CV-Risk Patients

Debate will continue about whether it's okay to use celecoxib (Celebrex, etc) in patients at high cardiovascular risk.

All NSAIDs have a warning about CV risk. But we're used to thinking that COX-2 inhibitors are riskier...especially since rofecoxib (Vioxx) was withdrawn due to an increased risk of MIs and strokes.

But celecoxib's CV risk may not be higher than other NSAIDs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote